Original ResearchPublished 11 September 2026Efficacy and safety of tapinarof cream once daily in Japanese pediatric patients with atopic dermatitis: a 60-week phase 3 trial consisting of an 8-week, double-blind, vehicle-controlled period and a 52-week, open-label extension periodAtsuyuki Igarashi · Gaku Tsuji · Ryusei Murata · Shuichi Fukasawa · Satoshi YamaneJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2026.17307